These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 33391505)

  • 1. Enhanced neprilysin-mediated degradation of hippocampal Aβ42 with a somatostatin peptide that enters the brain.
    Rofo F; Ugur Yilmaz C; Metzendorf N; Gustavsson T; Beretta C; Erlandsson A; Sehlin D; Syvänen S; Nilsson P; Hultqvist G
    Theranostics; 2021; 11(2):789-804. PubMed ID: 33391505
    [No Abstract]   [Full Text] [Related]  

  • 2. Wide-Ranging Effects on the Brain Proteome in a Transgenic Mouse Model of Alzheimer's Disease Following Treatment with a Brain-Targeting Somatostatin Peptide.
    Rofo F; Sandbaumhüter FA; Chourlia A; Metzendorf NG; Morrison JI; Syvänen S; Andrén PE; Jansson ET; Hultqvist G
    ACS Chem Neurosci; 2021 Jul; 12(13):2529-2541. PubMed ID: 34170117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood-brain barrier penetrating neprilysin degrades monomeric amyloid-beta in a mouse model of Alzheimer's disease.
    Rofo F; Metzendorf NG; Saubi C; Suominen L; Godec A; Sehlin D; Syvänen S; Hultqvist G
    Alzheimers Res Ther; 2022 Dec; 14(1):180. PubMed ID: 36471433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of immunotherapy with a brain penetrating Aβ antibody in a mouse model of Alzheimer's disease.
    Gustavsson T; Metzendorf NG; Wik E; Roshanbin S; Julku U; Chourlia A; Nilsson P; Andersson KG; Laudon H; Hultqvist G; Syvänen S; Sehlin D
    Alzheimers Res Ther; 2023 May; 15(1):90. PubMed ID: 37131196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient clearance of Aβ protofibrils in AβPP-transgenic mice treated with a brain-penetrating bifunctional antibody.
    Syvänen S; Hultqvist G; Gustavsson T; Gumucio A; Laudon H; Söderberg L; Ingelsson M; Lannfelt L; Sehlin D
    Alzheimers Res Ther; 2018 May; 10(1):49. PubMed ID: 29793530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
    Shackleton B; Crawford F; Bachmeier C
    Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of amyloid-beta levels in mouse eye tissues by intra-vitreally delivered neprilysin.
    Parthasarathy R; Chow KM; Derafshi Z; Fautsch MP; Hetling JR; Rodgers DW; Hersh LB; Pepperberg DR
    Exp Eye Res; 2015 Sep; 138():134-44. PubMed ID: 26142956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abeta-degrading endopeptidase, neprilysin, in mouse brain: synaptic and axonal localization inversely correlating with Abeta pathology.
    Fukami S; Watanabe K; Iwata N; Haraoka J; Lu B; Gerard NP; Gerard C; Fraser P; Westaway D; St George-Hyslop P; Saido TC
    Neurosci Res; 2002 May; 43(1):39-56. PubMed ID: 12074840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transferrin Receptor Binding BBB-Shuttle Facilitates Brain Delivery of Anti-Aβ-Affibodies.
    Faresjö R; Lindberg H; Ståhl S; Löfblom J; Syvänen S; Sehlin D
    Pharm Res; 2022 Jul; 39(7):1509-1521. PubMed ID: 35538266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin slows Aβ plaque deposition in aged APP
    Williams D; Yan BQ; Wang H; Negm L; Sackmann C; Verkuyl C; Rezai-Stevens V; Eid S; Vediya N; Sato C; Watts JC; Wille H; Schmitt-Ulms G
    Sci Rep; 2023 Feb; 13(1):2337. PubMed ID: 36759538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
    Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
    J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-Brain Barrier Penetrating Biologic TNF-α Inhibitor for Alzheimer's Disease.
    Chang R; Knox J; Chang J; Derbedrossian A; Vasilevko V; Cribbs D; Boado RJ; Pardridge WM; Sumbria RK
    Mol Pharm; 2017 Jul; 14(7):2340-2349. PubMed ID: 28514851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant soluble neprilysin reduces amyloid-beta accumulation and improves memory impairment in Alzheimer's disease mice.
    Park MH; Lee JK; Choi S; Ahn J; Jin HK; Park JS; Bae JS
    Brain Res; 2013 Sep; 1529():113-24. PubMed ID: 23831521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor-mediated abeta amyloid antibody targeting to Alzheimer's disease mouse brain.
    Zhou QH; Fu A; Boado RJ; Hui EK; Lu JZ; Pardridge WM
    Mol Pharm; 2011 Feb; 8(1):280-5. PubMed ID: 21141969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of huprine X on β-amyloid, synaptophysin and α7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice.
    Hedberg MM; Clos MV; Ratia M; Gonzalez D; Lithner CU; Camps P; Muñoz-Torrero D; Badia A; Giménez-Llort L; Nordberg A
    Neurodegener Dis; 2010; 7(6):379-88. PubMed ID: 20689242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin regulates brain amyloid beta peptide Abeta42 through modulation of proteolytic degradation.
    Saito T; Iwata N; Tsubuki S; Takaki Y; Takano J; Huang SM; Suemoto T; Higuchi M; Saido TC
    Nat Med; 2005 Apr; 11(4):434-9. PubMed ID: 15778722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GEPT extract reduces Abeta deposition by regulating the balance between production and degradation of Abeta in APPV717I transgenic mice.
    Tian J; Shi J; Zhang L; Yin J; Hu Q; Xu Y; Sheng S; Wang P; Ren Y; Wang R; Wang Y
    Curr Alzheimer Res; 2009 Apr; 6(2):118-31. PubMed ID: 19355846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin Signaling Differentially Regulates the Trafficking of Insulin and Amyloid Beta Peptides at the Blood-Brain Barrier.
    Zhou AL; Swaminathan SK; Salian VS; Wang L; Curran GL; Min HK; Lowe VJ; Kandimalla KK
    Mol Pharm; 2024 May; 21(5):2176-2186. PubMed ID: 38625027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etiology of sporadic Alzheimer's disease: somatostatin, neprilysin, and amyloid beta peptide.
    Hama E; Saido TC
    Med Hypotheses; 2005; 65(3):498-500. PubMed ID: 15921860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A neuroprotective brain-penetrating endopeptidase fusion protein ameliorates Alzheimer disease pathology and restores neurogenesis.
    Spencer B; Verma I; Desplats P; Morvinski D; Rockenstein E; Adame A; Masliah E
    J Biol Chem; 2014 Jun; 289(25):17917-31. PubMed ID: 24825898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.